Determine the necessary mass, volume, or concentration for preparing a solution.
Nirsevimab (anti-RSV) (Ab182791) - SEC
The purity of Nirsevimab (anti-RSV) (Ab182791) is more than 95% verified by HPLC.
Nirsevimab (anti-RSV) - Primary antibody, specific to RSV, Human IgG1, INHIBITOR of Fusion glycoprotein F0 inhibitor, INHIBITOR of Fusion glycoprotein F0 inhibitor
AVAILABLE TO ORDER
GRADE & PURITY Animal Free ? Animal-free — produced without animal-derived components to reduce contamination risk. Use in biomanufacturing and culture avoiding animal-origin material. Carrier Free ? Carrier-free — supplied without added carrier protein/stabilizer. Use when carriers (e.g. BSA) would interfere with conjugation or sensitive assays. Recombinant ? Recombinant — produced via recombinant expression for defined sequence and consistency. Use for reproducible, animal-free proteins of known origin. Validated ? Validated grade — performance confirmed in defined applications before release. Use when you want documented assurance the reagent works as stated. Low Endotoxin ? Low-endotoxin grade — endotoxin reduced to low controlled levels. Use in sensitive biological work where high endotoxin would interfere. Azide Free ? Azide-free — without sodium azide preservative. Use in conjugations, cell work, or assays where azide is toxic or inhibitory. PBS Only ? PBS-only formulation — supplied in phosphate-buffered saline with no other additives. Use when you need a clean PBS buffer free of stabilizers/carriers. ≥95%(SDS-PAGE&SEC-HPLC) See COA
Application
Animal Model, ELISA, Flow Cytometry, Functional Assay
Host species
Human
Reactive species
Respiratory syncytial virus
Isotype
Human IgG1
Conjugation
Unconjugated